Cargando…

Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion

Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbayo, Elisa, Gavira, Juan José, de Yebenes, Manuel Garcia, Pelacho, Beatriz, Abizanda, Gloria, Lana, Hugo, Blanco-Prieto, María José, Prosper, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868965/
https://www.ncbi.nlm.nih.gov/pubmed/27184924
http://dx.doi.org/10.1038/srep25932
_version_ 1782432237065601024
author Garbayo, Elisa
Gavira, Juan José
de Yebenes, Manuel Garcia
Pelacho, Beatriz
Abizanda, Gloria
Lana, Hugo
Blanco-Prieto, María José
Prosper, Felipe
author_facet Garbayo, Elisa
Gavira, Juan José
de Yebenes, Manuel Garcia
Pelacho, Beatriz
Abizanda, Gloria
Lana, Hugo
Blanco-Prieto, María José
Prosper, Felipe
author_sort Garbayo, Elisa
collection PubMed
description Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials.
format Online
Article
Text
id pubmed-4868965
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48689652016-05-31 Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion Garbayo, Elisa Gavira, Juan José de Yebenes, Manuel Garcia Pelacho, Beatriz Abizanda, Gloria Lana, Hugo Blanco-Prieto, María José Prosper, Felipe Sci Rep Article Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials. Nature Publishing Group 2016-05-17 /pmc/articles/PMC4868965/ /pubmed/27184924 http://dx.doi.org/10.1038/srep25932 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Garbayo, Elisa
Gavira, Juan José
de Yebenes, Manuel Garcia
Pelacho, Beatriz
Abizanda, Gloria
Lana, Hugo
Blanco-Prieto, María José
Prosper, Felipe
Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title_full Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title_fullStr Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title_full_unstemmed Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title_short Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
title_sort catheter-based intramyocardial injection of fgf1 or nrg1-loaded mps improves cardiac function in a preclinical model of ischemia-reperfusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868965/
https://www.ncbi.nlm.nih.gov/pubmed/27184924
http://dx.doi.org/10.1038/srep25932
work_keys_str_mv AT garbayoelisa catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT gavirajuanjose catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT deyebenesmanuelgarcia catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT pelachobeatriz catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT abizandagloria catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT lanahugo catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT blancoprietomariajose catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion
AT prosperfelipe catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion